Completed
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
NCT03572036
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States